- Home
- QSI vs BHK Comparison
QSI vs BHK Comparison
Compare QSI & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QSI | BHK |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 665.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | QSI | BHK |
|---|---|---|
| Price | $0.95 | $9.07 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 308.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $196.35 | N/A |
| Revenue Next Year | $229.03 | N/A |
| P/E Ratio | ★ N/A | $8.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $9.17 |
| 52 Week High | $3.10 | $11.00 |
Technical Indicators
Market Signals| Indicator | QSI | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 16.20 |
| Support Level | $0.90 | N/A |
| Resistance Level | $1.03 | $9.72 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 38.99 | 7.50 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.